Related Experiment Video
Updated: Aug 5, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Psychopharmacology and Neurocognitive Disorders: Evidence for Cognitive and Behavioral Symptom Management
Cody Olson1, Marlene Maria Girón Bravo1, Gisela Gonzalez1
1Department of Psychiatry, University of Texas Southwestern, Dallas.
None:
Neurocognitive disorders (NCDs) encompass various conditions that affect cognition and functioning in activities of daily living. Although many types of NCDs lack curative therapy, medications may be used to ameliorate cognitive as well as behavioral and psychological symptoms of dementia (BPSD). Medications classified as acetylcholinesterase inhibitors, N-methyl-D-aspartate receptor antagonists, and antiamyloid monoclonal antibodies target cognitive symptoms. For BPSD, antidepressants, antipsychotics, mood stabilizers, anxiolytics, and stimulants have been studied. Selection of pharmacotherapies requires careful risk-benefit analysis for individual patients. This review discusses available evidence to guide these discussions and clinical decisions.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Mania and Antimanic Drugs: Overview
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
